Backtest 317 — Systematic 1D strategy on US equities (CAGR 30%, MaxDD 18%)
Backtest 317 evaluates a long-only, daily-bar systematic strategy on a broad universe of 4,176 US-listed equities from 1 March 2016 to 30 April 2026 (≈ 10 years 2 months). Over that window the strategy compounds to a CAGR of 30.4% Read more







